Shiina H, Yasumoto H, Hiraki M, Arichi N, Mitsui Y, Hiraoka T, Sumura M, Honda S, Igawa M: Versican is a promising candidate biomarker in the combination of docetaxel with thalidomide as second line chemotherapy in castration-resistant prostate cancer after docetaxel resistance. The 107ｔｈ American Urological Association.San Atlanta, May 19–23, 2012
Sumura M, Anjiki H, Kobara C, Inoue K, Arichi N, Mitsui Y, Hiraoka T, Honda S Yasumoto H, Shiina H, Yoshizako T, Kitagaki H, Igawa M:Prostate cancer detection using real-time tissue elastography in patients with lower PSA levels. The 107ｔｈ American Urological Association.San Atlanta, May 19–23, 2012
Satoshi Honda, Haruki Anjiki, Keita Inoue, Chiaki Kobara, Naoko Arichi, Yozo Mitsui,Takeo Hiraoka, Masahiro Sumura, Hiroaki Yasumoto, Hiroaki Shiina, Mikio Igawa: Clinical experience with transurethral resection of bladder tumor(TURBT) and ureteroscopic examination of ureteral tumor guided by photodynamic diagnosis (PDD). 11th Asian Congress of Urology. Thailand Aug 22-26 2012
Yozo Mitsui, Hiroaki Shiina, Teruki Anjiki, Keita Inoue, Chiaki Kobara, Naoko Arichi, Masahiro Sumura, Satoshi Honda, Hiroaki Yasumoto, Mikio Igawa : Prostatocystectomy for advanced bladder cancer -hybrid procedure using perineal and abdominal approach-. 11th Asian Congress of Urology. Thailand Aug 22-26 2012
Naoko Arichi, Yozo Mitsui, Keita Inoue, Chiaki Kobara, Takeo Hiraoka, Masahiro Sumura, Satoshi Honda, Hiroaki Yasumoto, Hiroaki Shiina and Mikio Igawa : R.E.N.A.L. nephrometry score can predict pathological features and clinical outcomes of renal cell carcinoma . 11th Asian Congress of Urology. Thailand Aug 22-26 2012
Mitsui Y, Yasumoto H, Arichi N, Honda S, Shiina H, Igawa M : Current chemotherapeutic strategies against bladder cancer. Int Urol Nephrol. 44(2):431-41.2012.04
Mitsui Y, Shiina H, Hiraki M, Arichi N, Hiraoka T, Sumura M, Honda S, Yasumoto H, Igawa M : Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer–novel predictor of biochemical recurrence after radical surgery. Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):487-96.
Mitsui Y, Shiina H, Arichi N, Hiraoka T, Inoue S, Sumura M, Honda S, Yasumoto H, Igawa M : Indocyanine green (ICG)-based fluorescence navigation system for discrimination of kidney cancer from normal parenchyma: application during partial nephrectomy. Int Urol Nephrol. 2012 Jun;44(3):753-9.
Mitsui Y, Shiina H, Yamamoto Y, Haramoto M, Arichi N, Yasumoto H, Kitagaki H Igawa M: Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer. BJU int in pres
Mitsui Y, Hiroaki Shiina, Takeo Hiraoka, Naoko Arichi, Hiroaki Yasumoto, Rajvir Dahiya, Emil A. Tanagho, and Mikio Igawa: Simultaneous implantation of bilateral ureters into bladder acellular matrix graft after partial cystectomy in a porcine model. BJU int in press
Mitsui Y. Editorial Comment from Dr Mitsui to Association of RENAL nephrometry score with outcomes of minimally invasive partial nephrectomy. Int J Urol. 2012 Nov 28.
Shiina H. Editorial comment from Dr Shiina to Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: a meta-analysis. Int J Urol. 2012 Oct;19(10):921-22
Inoue S, Shiina H, Igawa M. Paget’s disease of the vulva with bladder invasion: a case report. Arch Gynecol Obstet. 2012 May ;285(5):1493-6.
Inoue S, Shiina H, Mitsui Y, Yasumoto H, Matsubara A, Igawa M. Identification of lymphatic pathway involved in the spread of bladder cancer: Evidence obtained from fluorescence navigation with intraoperatively injected indocyanine green. Can Urol Assoc J. 2012 Sep 10:1-7
Yoshizako T, Uchida K, Hara S, Kaji Y, Sumura M, Igawa M, Kitagaki H, Uike M, Matsuda T. Prostate 3T-MR spectroscopic imaging without an endorectal surface coil using the MLEV-PRESS sequence. Jpn J Radiol. 2012 Dec 5